nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—Breast feeding—Octreotide—thymus cancer	0.0361	0.0396	CcSEcCtD
Carbamazepine—Hepatitis cholestatic—Octreotide—thymus cancer	0.0313	0.0343	CcSEcCtD
Carbamazepine—Intraocular pressure increased—Octreotide—thymus cancer	0.0287	0.0314	CcSEcCtD
Carbamazepine—Appetite absent—Octreotide—thymus cancer	0.0254	0.0278	CcSEcCtD
Carbamazepine—Pregnancy—Octreotide—thymus cancer	0.0222	0.0244	CcSEcCtD
Carbamazepine—Fracture—Octreotide—thymus cancer	0.0217	0.0238	CcSEcCtD
Carbamazepine—Multiple fractures—Octreotide—thymus cancer	0.0217	0.0238	CcSEcCtD
Carbamazepine—Transaminases increased—Octreotide—thymus cancer	0.0207	0.0227	CcSEcCtD
Carbamazepine—Galactorrhoea—Octreotide—thymus cancer	0.0195	0.0213	CcSEcCtD
Carbamazepine—Neuralgia—Octreotide—thymus cancer	0.0182	0.0199	CcSEcCtD
Carbamazepine—Neuritis—Octreotide—thymus cancer	0.0169	0.0185	CcSEcCtD
Carbamazepine—Endocrine disorder—Octreotide—thymus cancer	0.0152	0.0167	CcSEcCtD
Carbamazepine—Drug interaction—Octreotide—thymus cancer	0.0136	0.0149	CcSEcCtD
Carbamazepine—Hearing impaired—Octreotide—thymus cancer	0.0133	0.0145	CcSEcCtD
Carbamazepine—Muscle twitching—Octreotide—thymus cancer	0.0129	0.0141	CcSEcCtD
Carbamazepine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0126	0.0138	CcSEcCtD
Carbamazepine—Cramps of lower extremities—Octreotide—thymus cancer	0.0116	0.0127	CcSEcCtD
Carbamazepine—Gynaecomastia—Octreotide—thymus cancer	0.0113	0.0124	CcSEcCtD
Carbamazepine—Hyperkinesia—Octreotide—thymus cancer	0.011	0.0121	CcSEcCtD
Carbamazepine—Thrombophlebitis—Octreotide—thymus cancer	0.0106	0.0116	CcSEcCtD
Carbamazepine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0105	0.0115	CcSEcCtD
Carbamazepine—Polyuria—Octreotide—thymus cancer	0.0104	0.0114	CcSEcCtD
Carbamazepine—Deafness—Octreotide—thymus cancer	0.0102	0.0112	CcSEcCtD
Carbamazepine—Cardiac failure congestive—Octreotide—thymus cancer	0.0101	0.0111	CcSEcCtD
Carbamazepine—Injury—Octreotide—thymus cancer	0.00997	0.0109	CcSEcCtD
Carbamazepine—Amnesia—Octreotide—thymus cancer	0.00975	0.0107	CcSEcCtD
Carbamazepine—Osteoarthritis—Octreotide—thymus cancer	0.00916	0.01	CcSEcCtD
Carbamazepine—Psychotic disorder—Octreotide—thymus cancer	0.00895	0.0098	CcSEcCtD
Carbamazepine—Irritability—Octreotide—thymus cancer	0.00875	0.00958	CcSEcCtD
Carbamazepine—Cramp muscle—Octreotide—thymus cancer	0.00825	0.00904	CcSEcCtD
Carbamazepine—Muscular weakness—Octreotide—thymus cancer	0.00808	0.00885	CcSEcCtD
Carbamazepine—Pancreatitis—Octreotide—thymus cancer	0.00776	0.0085	CcSEcCtD
Carbamazepine—Sweating increased—Octreotide—thymus cancer	0.00771	0.00845	CcSEcCtD
Carbamazepine—Bronchitis—Octreotide—thymus cancer	0.00762	0.00834	CcSEcCtD
Carbamazepine—Abdominal discomfort—Octreotide—thymus cancer	0.00759	0.00831	CcSEcCtD
Carbamazepine—Pollakiuria—Octreotide—thymus cancer	0.00732	0.00801	CcSEcCtD
Carbamazepine—Weight increased—Octreotide—thymus cancer	0.00721	0.00789	CcSEcCtD
Carbamazepine—Hyperglycaemia—Octreotide—thymus cancer	0.00714	0.00782	CcSEcCtD
Carbamazepine—Pneumonia—Octreotide—thymus cancer	0.0071	0.00778	CcSEcCtD
Carbamazepine—Drowsiness—Octreotide—thymus cancer	0.00706	0.00773	CcSEcCtD
Carbamazepine—Depression—Octreotide—thymus cancer	0.00704	0.00771	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Octreotide—thymus cancer	0.00692	0.00758	CcSEcCtD
Carbamazepine—Jaundice—Octreotide—thymus cancer	0.00688	0.00754	CcSEcCtD
Carbamazepine—Conjunctivitis—Octreotide—thymus cancer	0.00686	0.00752	CcSEcCtD
Carbamazepine—Urinary tract infection—Octreotide—thymus cancer	0.00686	0.00752	CcSEcCtD
Carbamazepine—Haematuria—Octreotide—thymus cancer	0.00673	0.00737	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Octreotide—thymus cancer	0.00668	0.00731	CcSEcCtD
Carbamazepine—Sinusitis—Octreotide—thymus cancer	0.00662	0.00726	CcSEcCtD
Carbamazepine—Bradycardia—Octreotide—thymus cancer	0.00645	0.00707	CcSEcCtD
Carbamazepine—Rhinitis—Octreotide—thymus cancer	0.00636	0.00696	CcSEcCtD
Carbamazepine—RALBP1—hematopoietic system—thymus cancer	0.00635	0.0731	CbGeAlD
Carbamazepine—Hepatitis—Octreotide—thymus cancer	0.00634	0.00694	CcSEcCtD
Carbamazepine—Pharyngitis—Octreotide—thymus cancer	0.00629	0.00689	CcSEcCtD
Carbamazepine—Oedema peripheral—Octreotide—thymus cancer	0.00624	0.00684	CcSEcCtD
Carbamazepine—Tinnitus—Octreotide—thymus cancer	0.00591	0.00647	CcSEcCtD
Carbamazepine—Flushing—Octreotide—thymus cancer	0.00588	0.00644	CcSEcCtD
Carbamazepine—Cardiac disorder—Octreotide—thymus cancer	0.00588	0.00644	CcSEcCtD
Carbamazepine—Immune system disorder—Octreotide—thymus cancer	0.00573	0.00627	CcSEcCtD
Carbamazepine—Arrhythmia—Octreotide—thymus cancer	0.00566	0.0062	CcSEcCtD
Carbamazepine—Alopecia—Octreotide—thymus cancer	0.0056	0.00613	CcSEcCtD
Carbamazepine—Mental disorder—Octreotide—thymus cancer	0.00555	0.00608	CcSEcCtD
Carbamazepine—Malnutrition—Octreotide—thymus cancer	0.00552	0.00604	CcSEcCtD
Carbamazepine—Erythema—Octreotide—thymus cancer	0.00552	0.00604	CcSEcCtD
Carbamazepine—Tension—Octreotide—thymus cancer	0.00542	0.00593	CcSEcCtD
Carbamazepine—Nervousness—Octreotide—thymus cancer	0.00536	0.00587	CcSEcCtD
Carbamazepine—Back pain—Octreotide—thymus cancer	0.00534	0.00585	CcSEcCtD
Carbamazepine—Muscle spasms—Octreotide—thymus cancer	0.00531	0.00581	CcSEcCtD
Carbamazepine—Vision blurred—Octreotide—thymus cancer	0.0052	0.0057	CcSEcCtD
Carbamazepine—Tremor—Octreotide—thymus cancer	0.00517	0.00566	CcSEcCtD
Carbamazepine—Anaemia—Octreotide—thymus cancer	0.0051	0.00559	CcSEcCtD
Carbamazepine—Agitation—Octreotide—thymus cancer	0.00507	0.00555	CcSEcCtD
Carbamazepine—Vertigo—Octreotide—thymus cancer	0.00496	0.00543	CcSEcCtD
Carbamazepine—Syncope—Octreotide—thymus cancer	0.00495	0.00542	CcSEcCtD
Carbamazepine—SCN9A—pituitary gland—thymus cancer	0.00487	0.0561	CbGeAlD
Carbamazepine—Loss of consciousness—Octreotide—thymus cancer	0.00485	0.00531	CcSEcCtD
Carbamazepine—RALBP1—cardiac atrium—thymus cancer	0.00483	0.0555	CbGeAlD
Carbamazepine—Convulsion—Octreotide—thymus cancer	0.00478	0.00524	CcSEcCtD
Carbamazepine—Hypertension—Octreotide—thymus cancer	0.00476	0.00522	CcSEcCtD
Carbamazepine—RALBP1—pituitary gland—thymus cancer	0.00471	0.0542	CbGeAlD
Carbamazepine—Arthralgia—Octreotide—thymus cancer	0.0047	0.00515	CcSEcCtD
Carbamazepine—Myalgia—Octreotide—thymus cancer	0.0047	0.00515	CcSEcCtD
Carbamazepine—Chest pain—Octreotide—thymus cancer	0.0047	0.00515	CcSEcCtD
Carbamazepine—Anxiety—Octreotide—thymus cancer	0.00468	0.00513	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00467	0.00511	CcSEcCtD
Carbamazepine—Dry mouth—Octreotide—thymus cancer	0.00459	0.00503	CcSEcCtD
Carbamazepine—Oedema—Octreotide—thymus cancer	0.0045	0.00493	CcSEcCtD
Carbamazepine—Anaphylactic shock—Octreotide—thymus cancer	0.0045	0.00493	CcSEcCtD
Carbamazepine—Infection—Octreotide—thymus cancer	0.00447	0.0049	CcSEcCtD
Carbamazepine—Shock—Octreotide—thymus cancer	0.00443	0.00485	CcSEcCtD
Carbamazepine—Nervous system disorder—Octreotide—thymus cancer	0.00442	0.00484	CcSEcCtD
Carbamazepine—Thrombocytopenia—Octreotide—thymus cancer	0.00441	0.00483	CcSEcCtD
Carbamazepine—Tachycardia—Octreotide—thymus cancer	0.0044	0.00481	CcSEcCtD
Carbamazepine—Skin disorder—Octreotide—thymus cancer	0.00437	0.00479	CcSEcCtD
Carbamazepine—Hyperhidrosis—Octreotide—thymus cancer	0.00435	0.00477	CcSEcCtD
Carbamazepine—SCN4A—pituitary gland—thymus cancer	0.00435	0.05	CbGeAlD
Carbamazepine—Anorexia—Octreotide—thymus cancer	0.00429	0.0047	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0041	0.00449	CcSEcCtD
Carbamazepine—RALBP1—bone marrow—thymus cancer	0.00407	0.0469	CbGeAlD
Carbamazepine—Insomnia—Octreotide—thymus cancer	0.00407	0.00446	CcSEcCtD
Carbamazepine—RALBP1—thyroid gland—thymus cancer	0.00406	0.0468	CbGeAlD
Carbamazepine—Paraesthesia—Octreotide—thymus cancer	0.00404	0.00443	CcSEcCtD
Carbamazepine—Dyspnoea—Octreotide—thymus cancer	0.00402	0.0044	CcSEcCtD
Carbamazepine—Somnolence—Octreotide—thymus cancer	0.004	0.00438	CcSEcCtD
Carbamazepine—Dyspepsia—Octreotide—thymus cancer	0.00396	0.00434	CcSEcCtD
Carbamazepine—Decreased appetite—Octreotide—thymus cancer	0.00391	0.00429	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00389	0.00426	CcSEcCtD
Carbamazepine—Fatigue—Octreotide—thymus cancer	0.00388	0.00425	CcSEcCtD
Carbamazepine—Pain—Octreotide—thymus cancer	0.00385	0.00422	CcSEcCtD
Carbamazepine—Constipation—Octreotide—thymus cancer	0.00385	0.00422	CcSEcCtD
Carbamazepine—SCN9A—lung—thymus cancer	0.00381	0.0439	CbGeAlD
Carbamazepine—SCN4A—thyroid gland—thymus cancer	0.00375	0.0431	CbGeAlD
Carbamazepine—Feeling abnormal—Octreotide—thymus cancer	0.00371	0.00406	CcSEcCtD
Carbamazepine—RALBP1—lung—thymus cancer	0.00369	0.0425	CbGeAlD
Carbamazepine—Gastrointestinal pain—Octreotide—thymus cancer	0.00368	0.00403	CcSEcCtD
Carbamazepine—Urticaria—Octreotide—thymus cancer	0.00358	0.00392	CcSEcCtD
Carbamazepine—Abdominal pain—Octreotide—thymus cancer	0.00356	0.0039	CcSEcCtD
Carbamazepine—Body temperature increased—Octreotide—thymus cancer	0.00356	0.0039	CcSEcCtD
Carbamazepine—SCN5A—cardiac atrium—thymus cancer	0.00345	0.0397	CbGeAlD
Carbamazepine—Hypersensitivity—Octreotide—thymus cancer	0.00332	0.00363	CcSEcCtD
Carbamazepine—Asthenia—Octreotide—thymus cancer	0.00323	0.00354	CcSEcCtD
Carbamazepine—Pruritus—Octreotide—thymus cancer	0.00319	0.00349	CcSEcCtD
Carbamazepine—Diarrhoea—Octreotide—thymus cancer	0.00308	0.00337	CcSEcCtD
Carbamazepine—Dizziness—Octreotide—thymus cancer	0.00298	0.00326	CcSEcCtD
Carbamazepine—CYP2C19—hematopoietic system—thymus cancer	0.00293	0.0337	CbGeAlD
Carbamazepine—Vomiting—Octreotide—thymus cancer	0.00286	0.00314	CcSEcCtD
Carbamazepine—Rash—Octreotide—thymus cancer	0.00284	0.00311	CcSEcCtD
Carbamazepine—Dermatitis—Octreotide—thymus cancer	0.00284	0.00311	CcSEcCtD
Carbamazepine—Headache—Octreotide—thymus cancer	0.00282	0.00309	CcSEcCtD
Carbamazepine—Nausea—Octreotide—thymus cancer	0.00268	0.00293	CcSEcCtD
Carbamazepine—SCN9A—lymph node—thymus cancer	0.00261	0.03	CbGeAlD
Carbamazepine—CYP2C8—hematopoietic system—thymus cancer	0.00256	0.0294	CbGeAlD
Carbamazepine—RALBP1—lymph node—thymus cancer	0.00252	0.029	CbGeAlD
Carbamazepine—CYP1A2—hematopoietic system—thymus cancer	0.00239	0.0275	CbGeAlD
Carbamazepine—CYP3A5—hematopoietic system—thymus cancer	0.00231	0.0265	CbGeAlD
Carbamazepine—CYP2B6—hematopoietic system—thymus cancer	0.00229	0.0264	CbGeAlD
Carbamazepine—CYP2C9—hematopoietic system—thymus cancer	0.00227	0.0261	CbGeAlD
Carbamazepine—CYP2C8—pituitary gland—thymus cancer	0.0019	0.0218	CbGeAlD
Carbamazepine—CYP3A4—hematopoietic system—thymus cancer	0.00173	0.0199	CbGeAlD
Carbamazepine—CYP2B6—lymphoid tissue—thymus cancer	0.00161	0.0186	CbGeAlD
Carbamazepine—CYP1A2—thyroid gland—thymus cancer	0.00153	0.0176	CbGeAlD
Carbamazepine—CYP1A2—lung—thymus cancer	0.00139	0.016	CbGeAlD
Carbamazepine—ABCC2—lymph node—thymus cancer	0.00135	0.0156	CbGeAlD
Carbamazepine—CYP3A5—lung—thymus cancer	0.00134	0.0154	CbGeAlD
Carbamazepine—CYP2B6—lung—thymus cancer	0.00133	0.0153	CbGeAlD
Carbamazepine—ABCB1—hematopoietic system—thymus cancer	0.00123	0.0141	CbGeAlD
Carbamazepine—ABCB1—epithelium—thymus cancer	0.00112	0.0129	CbGeAlD
Carbamazepine—ABCB1—pituitary gland—thymus cancer	0.000909	0.0105	CbGeAlD
Carbamazepine—ABCB1—lymphoid tissue—thymus cancer	0.000863	0.00993	CbGeAlD
Carbamazepine—ABCB1—bone marrow—thymus cancer	0.000786	0.00904	CbGeAlD
Carbamazepine—ABCB1—thyroid gland—thymus cancer	0.000784	0.00902	CbGeAlD
Carbamazepine—ABCB1—lung—thymus cancer	0.000712	0.00819	CbGeAlD
Carbamazepine—ABCB1—lymph node—thymus cancer	0.000487	0.0056	CbGeAlD
